← Can-Fite BioPharma Ltd.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net loss | ($27.0m) | ($5.0m) | ($6.6m) | ($9.6m) | ($14.4m) | ($12.6m) | ($10.2m) | ($7.6m) | ($7.9m) | ($9.8m) | — | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | ($8.4m) | ($6.4m) | ($6.6m) | ($12.6m) | ($14.4m) | ($12.6m) | ($10.2m) | ($7.6m) | ($7.9m) | ($9.8m) | — | |
| Depreciation, Depletion and Amortization | — | — | — | $14k | $12k | $14k | $14k | $15k | $7k | $24k | $24k | |
| Depreciation of property, plant and equipment | $71k | $20k | $14k | $14k | $12k | $14k | $14k | $15k | $7k | $24k | $24k | |
| Share-based Payment Arrangement, Noncash Expense | — | — | $535k | $385k | $355k | $68k | $263k | $261k | $362k | $340k | $340k | |
| Adjustments For Share-Based Payments | $322k | $192k | $535k | $385k | — | — | — | — | — | — | — | |
| Share-based Payment Arrangement, Expense | — | — | — | — | — | — | — | $261k | $362k | $340k | $340k | |
| Nonoperating Income (Expense) | — | — | — | ($618k) | ($304k) | $227k | ($77k) | $561k | $250k | $122k | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | — | — | — | ($270k) | — | — | — | — | — | — | — | |
| Increase (decrease) in other accounts payable | ($631k) | $22k | $125k | ($512k) | ($279k) | $574k | ($130k) | $169k | $32k | $133k | — | |
| Decrease in deferred revenues | — | — | $1.2m | $146k | ($401k) | $1.4m | ($810k) | ($743k) | ($349k) | ($405k) | — | |
| Change in prepaid expenses, and other current assets | — | — | ($853k) | $270k | $2.7m | $128k | ($241k) | $184k | ($109k) | $195k | — | |
| Net Cash Provided by (Used in) Operating Activities | ($34.3m) |
($9.5m)
+72.20%
|
($4.2m)
+56.47%
|
($10.8m)
-160.75%
|
($12.1m)
-11.34%
|
($9.9m)
+18.28%
|
($10.8m)
-9.57%
|
($8.4m)
+21.86%
|
($7.6m)
+9.51%
|
($8.9m)
-17.18%
|
($8.9m)
0.00%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | ($40k) | ($7k) | ($33k) | $3k | $26k | $11k | $9k | $2k | $5k | $2k | ($2k) | |
| Cash, Cash Equivalents, and Short-term Investments | — | — | — | — | — | — | — | $8.9m | $7.9m | — | — | |
| Gain (Loss) on Investments | — | — | — | — | $11k | $162k | — | — | — | — | — | |
| Net Cash Provided by (Used in) Investing Activities | ($40k) | ($30k) | ($33k) | ($253k) | ($26k) | ($14.5m) | $9.5m | $498k | $1.5m | ($2k) | ($2k) | |
| Cash flows from financing activities: | ||||||||||||
| Proceeds from Issuance of Common Stock | — | — | — | — | — | — | — | — | $2.2m | $2.9m | $9.6m | |
| Dividends paid | — | — | — | — | — | $3 | — | — | — | — | — | |
| Net Cash Provided by (Used in) Financing Activities | — | $4.9m |
$4.4m
-10.40%
|
$10.2m
+131.75%
|
$17.7m
+73.93%
|
$20.5m
+15.69%
|
— | $9.1m |
$6.7m
-26.61%
|
$9.6m
+43.70%
|
$9.6m
0.00%
|
|
| Increase (decrease) in cash and cash equivalents | ($34.8m) | ($5.5m) | $110k | ($918k) | $5.6m | ($3.9m) | ($1.4m) | $1.3m | $547k | $703k | — | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | — | — | $5.6m | ($3.9m) | ($1.4m) | $1.3m | $547k | $703k | $5.5m | |
| Cash and cash equivalents at the beginning of the year | $66.0m | $9.0m | $3.5m | $3.6m | $2.7m | $8.3m | $4.4m | $3.0m | $4.8m | $5.5m | — | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | — | — | — | — | — | $4.8m | $5.5m | $5.5m | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | — | — | — | ($113k) | $98k | ($22k) | $10k | $10k | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | — | — | $29k | $23k | $18k | — | — | — | — | — | |
| Additional Financial Items | ||||||||||||
| Adjustments For Increase Decrease In Trade Account Payable | $816k | ($293k) | $644k | $1.1m | — | — | — | — | — | — | — | |
| General and Administrative Expense | $2.7m | $2.9m | $3.2m | $3.1m | $3.0m | $3.8m | $3.1m | $3.0m | $3.0m | $3.7m | — | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | ($291k) | $284k | — | |
| Operating Expenses | — | — | — | — | — | — | — | — | $8.8m | $10.4m | — | |
| Payments Of Lease Liabilities Classified As Financing Activities | — | — | — | $34k | — | — | — | — | — | — | — | |
| Proceeds From Issuing Shares | — | $4.5m | $4.4m | $10.2m | — | — | — | — | — | — | — | |
| Revenue from Contract with Customer, Including Assessed Tax | — | — | — | — | — | — | — | $743k | — | — | — | |
| Reduction in the carrying amount of operating lease right of use asset | — | — | — | — | $9k | $55k | $54k | $94k | $37k | $42k | — | |
| Changes in fair value of short-term investment | — | $5k | $644k | $209k | ($11k) | ($162k) | $229k | ($11k) | $14k | $4k | — | |
| Financial expenses (income), net | — | — | — | ($2k) | $23k | ($34k) | $113k | ($222k) | $90k | $36k | — | |
| Decrease in operating lease liability | — | — | — | ($33k) | ($8k) | ($63k) | ($62k) | ($84k) | ($32k) | ($33k) | — | |
| Increase (decrease) in trade payable | — | — | $644k | $1.1m | ($1.6m) | $393k | ($58k) | ($469k) | $191k | $543k | — | |
| Maturity of short-term deposits, net | — | — | — | — | — | — | $9.5m | $500k | $1.5m | — | — | |
| Issuance of ordinary shares due to ATM, net of issuance costs | — | — | — | — | — | — | — | — | $2.2m | $2.9m | — | |
| Issuance of ordinary shares and warrants, net of issuance costs | — | — | — | — | — | — | — | $9.1m | $4.5m | $6.7m | — | |
| Exchange differences on balances of cash and cash equivalents | ($443k) | ($814k) | ($89k) | $2k | ($23k) | $34k | ($113k) | $98k | ($22k) | $10k | — | |
| Lease liabilities arising from obtaining right-of-use-assets | — | — | — | $76k | $29k | $120k | — | $62k | $96k | — | — |